BMS-650032

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
02420112015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
1. Asunaprevir (ASV, BMS-650032), a highly selective and potent NS3 protease inhibitor, is currently under development for the… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2015
2015
Asunaprevir (ASV; BMS-650032), a low nanomolar inhibitor of the hepatitis C virus (HCV) NS3 protease, is currently under… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Asunaprevir, a second-generation NS3 protease inhibitor of hepatitis C virus (HCV), exhibits strong antiviral activity against… (More)
Is this relevant?
2014
2014
The discovery of asunaprevir (BMS-650032, 24) is described. This tripeptidic acylsulfonamide inhibitor of the NS3/4A enzyme is… (More)
Is this relevant?
2013
2013
Asunaprevir (BMS-650032, ASV) is a potent, selective hepatitis C virus (HCV) NS3 protease inhibitor in clinical evaluation for… (More)
  • figure 1
  • table 3
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
With the development of directly acting antivirals, hepatitis C virus (HCV) therapy entered a new era. However, rapid selection… (More)
  • figure 1
  • table 3
  • table 4
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Asunaprevir (ASV; BMS-650032) is a hepatitis C virus (HCV) NS3 protease inhibitor that has demonstrated efficacy in patients… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor demonstrating efficacy in alfa interferon… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 4
Is this relevant?
2012
2012
Hepatitis C virus (HCV) protease inhibitors combined with pegylated alfa interferon-ribavirin have demonstrated improved efficacy… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2012
2012
Three hepatitis C virus (HCV) inhibitors, asunaprevir (ASV; BMS-650032), daclatasvir (DCV; BMS-790052), and BMS-791325, each… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?